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summary and conclusions
The distribution of receptors in the living brain can be visualized and quantified by
positron emission tomography (PE"f). Therefore, PET-studies may contribute to
diagnostic and therapeutic procedures. The method is based on the application of
tracer labeled with positron emitting nuclides. The visualized and quantified
distribution does not provide information on the state of the labeled substance:
free, nonspecifically- and specifically bound, or metabolized. To derive receptor
characteristics by PET - in terms of density and affinity for the applied ligand -
mathematical modelling is required. Modelling of in vivo binding and its experimentai
validation with respect to the dopamine D2 receptor - the prototype for
neuro-receptor PET - are the main themes of this thesis'
Concepts such as the characterization of cerebral dopamine receptors' in vivo
binding, and PET are introduced in chapter l- An outline of receptor theories and
binding models from the last 90 years is presented in chapter 2. The concept of the
membrane receptor developed from a pure theoretical term to a molecular defined
entity, functioning as an intermediate and modulator of signal transduction from the
extracellular to the intracellular environrnent. In addition, ligand binding modeis
were developed. Especially, the 'ternary complex' model is relevant with respect to
the dopamine D, receptor. In this model the ligand-receptor complex interacts with a
protein molecule, which functions as a transducer of the signal. In chapter 3 and 4,
in vivo binding models are outlined as far they are relevant for PET. A number of the
underlying assumptions is discussed and kinetic and equilibrium models are evaluated.
The state of equilibriumin a kinetic situation with a bolus administration can only
be approximated. However, it is shown by computer assisted simulations that the
equilibrium approach (pseudo-equilibrium) may lead to acceptable estimates of
receptor density, and in some advanced models (transient equilibrium) also to good
estimates of the density and affinity (chapter 4). In chapter 5, a method is
presented to detect the occurrence of a sigmoid binding curve, which can be
interpreted as evidence for cooperative binding. The method exists of a normalization
procedure of the accumulation in the region of interest with the accumulation in a
reference region, which lacks specific binding sites. The method is in particular
usable at low ligand doses. This latter feature is advantageous in clinical PET
studies. In vivo binding experiments with [3H]spiperone, a dopamine D, antagonist, in
rat striatum and frontal cortex are analyzed with a set of pseudo-equilibrium models
(chapter 6). It appears that the striatal data can not very well be described by a
classical equilibrium model, with bimolecular association and monomolecular
dissociation constants. Two alternative models suffice: cooperative binding in the
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the reference region. Both models lead to a peak-shaped curve when the ratio of the
striatal and cerebeliar accurnulation is plotted versus the cerebellar accumulation or
versus the dose. It is demonstrated by computer assisted simulations (chapter 7) that
this is also true - and sometimes even more pronounced - in a kinetic situation. If
these models are valid for the human brain, the consequence for PET is that the
striatal/cerebellar ratio is not an accurate index for specific binding. In recent
years PET has revealed contradictory results concerning the possible increase of the
dopamine D, density in the human caudate-putaÍnen in schizophrenic patients. In
particular, the results obtained with different ligands and different models (an
equilibrium model versus a kinetic model) are discrepant. An aspect of this kinetic
model - the model dependent correction of metabolites - is extensively evaluated in
chapter 8. It is concluded that this method leads to an underestimation of the
cerebellar distribution volume, and as a consequence, to an overestimation of the
receptor density. Possibly, the high dopamine D2 receptor density found in
schizophrenic patients may be attributed to differences in tracer metabolism. A
kinetic model is described in chapter 9. The accumulation of a tracer dose of
[3H]N-methylspiperone in the rat striatum is described in terms of the cerebeilar
accumulation. Until 200 min after administration of the ligand the accumulation of
the labeled ligand can be described by assuming a model with binding to a single
site. However, for the total duration of the experiment (400 min), an additional
irreversible binding process (e.9. binding to a second site or flow of specifically
bound ligand into a subsequent compartment) has to be supposed to obtain an
acceptable fit.
The main conclusions of the work presented in this thesis are summarized as follows:
1) Equilibrium models can be used for thq determination of receptor densities in aiao
in spite of the fact that a true equilibrium state can not be reached (chapter 4) in
a kinetic situation.
2) An initial positive slope of the plot of ratio of the accumulation in a region of
interest and in a region of reference versus versus the dose or versus a related
variable is indicative for a sigmoid binding curve in that region of interest. This
principle can be used to test the occurrence of such a sigmoidicity i,n uiuo with PET
(chapter 5).
3) A peak-shaped ratio curve has been found for [3H]ru-metnytspiperone- and
. 3 , , ,[-H]spiperone binding in the rat striaturn by multiple modelling with equilibrium
models. This indicates cooperative binding in the striatum or low capacity/high
affinity sites in the cerebellum (chapter 6).
4) The occurrence of cerebellar low capacity/high affinity sites do also lead to a
peak*shaped ratio curve in kinetic situations (chapter 7).
5) The model dependent correction for the appearance of plasma metabolites as applied
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by Wong and co-workers may lead to an overestimation of the receptor density
(chapter 8).
6) Multiple kinetic modelling of l3H]N-methylspiperone in the rat brain demonstrates
the occurrence of an additional irreversible binding process (chapter 9)'
7) The described models, as applied to animal studies, and the application of
multiple models to one set of data may provide an useful strategy for clinical PET
studies in the human brain (chapter 10).
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